Changes and Clinical Significance of Serum GM-CSF, IL-6 and TNF-α Levels in Patients with Rheumatoid Arthritis
10.13241/j.cnki.pmb.2017.24.025
- VernacularTitle:类风湿性关节炎患者血清GM-CSF,IL-6,TNF-α水平的变化及其临床意义
- Author:
Yaqin LI
;
Yong YAN
;
Min HUANG
;
Jing LI
;
Wei ZHANG
- Keywords:
Rheumatoid arthritis;
Granulocyte macrophage colony-stimulating factor;
Interleukin-6;
Tumor necrosis factor-α
- From:
Progress in Modern Biomedicine
2017;17(24):4702-4705
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the changes and clinical significances of serum levels of granulocyte macrophage colony-stimulating factor (GM-CSF),interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels in patients with rheumatoid arthritis (RA).Methods:126 cases of patients with RA in our hospital from June 2013 to December 2016 were selected as RA group and divided into two subgroups as active RA group (69 cases) and remission RA group (57 cases) according to the severity of the disease.55 healthy cases who receive physical check in our hospital at same time were selected as the control group.The serum GM-CSF,IL-6 TNF-α levels were detected by enzyme linked immunosorbent assay (ELISA) and compared between different groups,the correlation of serum GM-CSF,IL-6 TNF-α levels with DAS28 were analyzed.Results:The serum GM-CSF,IL-6 TNF-α levels of RA group were significantly higher than those of the remission RA group and control group (P＜0.01),and the serum GM-CSF,IL-6 TNF-α levels of remission RA group were also significantly higher than those of the control group (P＜0.01).Positive correlation between serum GM-CSF,IL-6 and TNF-α levels were found(P＜.0.01).The level of DAS28 was significantly correlated with the levels of serum GM-CSF,IL-6 and TNF-α (r=0.473,0.584,0.675,all P＜0.01).Conclusion:The levels of serum GM-CSF,IL-6 and TNF-α were up-regulated in patients with RA and positively correlated with the activity of RA,which might be of important clinical significance in the early diagnosis,disease evaluation and prognosis of RA.
